UPDATED Aug 07, 2026
Discover Belgian Pharmaceuticals & Biotech Growth Stocks that are on the BEL20. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
HYL | €4.51 | -5.8% | -29.8% | €131.6m | €12.30 | 15.9 | 98.0% | n/a | ||
ARGX | €753.80 | 1.0% | 30.9% | €46.8b | €899.15 | 31.7 | 22.6% | n/a | ||
UCB | €225.00 | 3.7% | 22.0% | €43.7b | €286.11 | 19.6 | 14.8% | 0.6% | ||
CYAD | €0.25 | -8.5% | -36.4% | €11.2m | n/a | 13.4 | n/a | n/a | ||
BIOS | €0.002 | 0% | -16.7% | €1.3m | n/a | -0.3 | n/a | n/a | ||
OXUR | €0.0026 | -7.1% | -91.3% | €230.6k | n/a | -0.1 | n/a | n/a | ||
TUB | €193.30 | 2.0% | 28.7% | €8.7b | €286.00 | 87.4 | n/a | 0.6% |